JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB317435

Anti-LRRC15 antibody [EPR8188(2)] Blocking Peptide

Be the first to review this product! Submit a review

|

(0 Publication)

Anti-LRRC15 antibody [EPR8188(2)] Blocking Peptide is a Synthetic peptide.

View Alternative Names

LIB, LRRC15, Leucine-rich repeat-containing protein 15, Leucine-rich repeat protein induced by beta-amyloid homolog, hLib

Key facts

Purity

undefined HPLC

Tags

Tag free

Biologically active

No

Accession

Q8TF66

Animal free

No

Carrier free

No

Species

Human

style
left-column
style
left-column

Product details

Reconstitute in either water or buffer. If the peptide doesn’t dissolve try an organic solvent like DMSO, then dilute using water or buffer. Gentle warming and sonication can effectively aid peptide solubilisation.
style
left-column

Sequence info

[{"sequence":null,"proteinLength":null,"predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Synthetic","expressionSystem":null,"accessionNumber":"Q8TF66","tags":[]}]
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage duration
Up to 12 months
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
False
style
left-column
style
left-column

General info

Function

(Microbial infection) Modulates the ability of SARS-CoV-2 to infect host cells through interaction with the spike protein (PubMed : 36228039, PubMed : 36735681, PubMed : 36757924). Does not act as a SARS-CoV-2 entry receptor but sequesters virions and antagonizes in trans SARS-CoV-2 infection of ACE2(+) cells when expressed on nearby cells (PubMed : 36228039, PubMed : 36757924).

style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

(Microbial infection) Modulates the ability of SARS-CoV-2 to infect host cells through interaction with the spike protein (PubMed : 36228039, PubMed : 36735681, PubMed : 36757924). Does not act as a SARS-CoV-2 entry receptor but sequesters virions and antagonizes in trans SARS-CoV-2 infection of ACE2(+) cells when expressed on nearby cells (PubMed : 36228039, PubMed : 36757924).
See full target information LRRC15
style
left-column
style
left-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
style
left-column
style
right-column
style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com